INDV
Indivior
$40.54
▼ -0.12%
−$0.05
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Indivior
INDV · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$40.54
▼ -0.12% · −$0.05 today
fundamentals77.5 /100 vs peers · 91% coverage
strong
5 of 5 metrics · 100% coverage
Revenue growth (TTM)10.3
27% below Sector 5Y avg avgSector 5Y avg: 14.1
EPS growth (TTM)998.2
8587% above Sector 5Y avg avg · favorableSector 5Y avg: 11.5
EPS forecast (5Y)18.6
29% above Sector fwd avg avg · favorableSector fwd avg: 14.5
EPS next year8.3
solid pace
EPS growth (Q/Q)83.5
strong pace
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| INDVIndivior | $4.79B | 20.8 | +10.3% | 78 |
| GMEDGlobus Medical | $10.60B | 18.2 | +23.5% | 78 |
| DXCMDexcom | $28.93B | 32.1 | +16.1% | 77 |
| LLYEli Lilly and Company | $1.12T | 42.8 | +47.4% | 76 |
| BSXBoston Scientific Corporation | $66.54B | 18.8 | +17.4% | 73 |
